Intranasal corticosteroids for first-line treatment of allergic rhinitis: What's the evidence?

Formulary

Volumn 36, Issue 4, 2001, Pages 276-293

  Stempel, D A ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DESLORATADINE; DEXCHLORPHENIRAMINE; DIPHENHYDRAMINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; LORATADINE; MOMETASONE FUROATE; MONTELUKAST; TERFENADINE; TRIAMCINOLONE ACETATE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST;

ALLERGIC RHINITIS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MARKETING; DRUG PACKAGING; DRUG POTENCY; DRUG SAFETY; HEALTH CARE COST; HUMAN; META ANALYSIS; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SEDATION; SENSITIZATION; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0035048438     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. A cost of illness study of allergic rhinitis in the United States
2. The prevalence of allergic rhinitis in the United States
3. Treatment of allergic rhinifis: An evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines
4. The economic impact of allergic rhinitis
5. Executive summary of joint task force practice parameters on diagnosis and management of rhinitis
6. Cognitive, social, and economic costs of allergic rhinitis
7. Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires
8. Cost of hay fever in the United States in 1990
9. Hay fever: An expensive disease for American business
10. Cost-effective pharmacotherapy for allergic rhinitis
11. The eternal triangle: Benefit, risk, and cost of therapeutic agents
12. Management of allergic rhinitis
13. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis
14. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis
15. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis
16. A comparative study of dexchlorpheniramine maleate sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis
17. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis
18. Oral antihistamine or nasal steroid in hay fever: A double-blind double-dummy study of once daily oral astemizole vs twice daily beclomethasone dipropionate
19. A comparison by rhinomanometry of beclomethasone and terfenadine in the treatment of seasonal rhinitis
20. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis
21. Doubleblind cross-over trial comparing beclomethasone dipropionate and terfenadine in perennial rhinitis
22. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis
23. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen
24. Budesonide and terfenadine, separately and in combination, in the treatment of hay fever
25. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis
26. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis
27. Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination
28. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis
29. Intranasal fluticasone once daily compared with once daily cetirizine in the treatment of seasonal allergic rhinitis
30. 1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials
31. Intranasal corticosteroids for allergic rhinitis: How do different agents compare?
32. Intranasal fluticasone propionate: A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis
33. Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: An active- and placebo-controlled study
34. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients
35. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal spray for the treatment of perennial allergic rhinitis
36. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial allergic rhinitis
37. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis
38. Systemic effects of intranasal steroids: An endocrinologist's perspective
39. Risk of cataract among users of intranasal corticosteroids
40. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate
41. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray
42. Growth in asthmatic children treated with fluticasone propionate
43. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis
44. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis
45. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis
46. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy
47. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
48. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis
49. Fluticasone propionate: An effective alternative treatment for seasonal allergic rhinitis in adults and adolescents
50. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis
51. Aqueous beclomethasone dipropionate nasal spray: Regular versus "as required" use in the treatment of seasonal allergic rhinitis
52. A comparison of costs and efficacy of fluticasone and terfenadine tablets for seasonal allergic rhinitis
53. Fluticasone propionate intranasal steroid: Cost-effectiveness vs antihistamines